Learn
Patient Navigation Program
Find Treatment Options
Expanded Access Programs
Brain Tumor Symptoms
Guide For High Grade Tumors
Guide For Low Grade Tumors
Checklist For Newly Diagnosed
Video Library
Noteworthy Treatments
Brain Tumor News
Survivor Stories
Fundraising
DC-Vax
Modeyso™(Onc-201) for DIPG/DMG
Optune
Temodar (Temozolomide)
GammaTile
Newsletter
Subscribe
Change Email
Unsubscribe
Archives
Virtual Trial
What is it?
Join
Submit An Update
Map of Participants
Resources
Copayment Assistance Program
Drug Discount Card
Brain Tumor Centers
Support Groups
Links To Other Resources
Books
Memorials
About Us
Musella Foundation
Research Grants
Recent Additions To Website
Privacy Policy
Ethics And Values
Our Sponsors
Financials
Contact
donations
Sponsored by
Please click on the above banner for more details
Brain Tumor News
Brain Tumor Conferences / Events
Brain Tumor News!
Subscribe to our Free Brain Tumor News Blast E-Mail Newsletter
Brain Tumor News Blast Archives
Submit a press release or abstract
Recent additions to this website!
Brain Tumor News!
Note: The comments under each article title are the
opinion
of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
Displaying Stories 2501 to 2520 of 7,673
Previous 20
Next 20
06/03/12
Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients.
06/03/12
Musella Foundation Co-Pay Assistance program is now closed!
05/30/12
Novocure to present NovoTTF Therapy Data at the 2012 Annual Scientific Meeting of the American Society Of Clinical Oncology!
05/28/12
The trouble with brain scans
05/27/12
Claudette Saville Felice on the Go Grey in May 5K
05/24/12
Novocure(TM) Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
05/23/12
Drug shrinks melanoma metastases in the brain
05/23/12
IBTA Newsletter
05/22/12
Coping with Side Effects of Medications
05/21/12
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastom: a randomized phase 3 trial of a novel treatment modality. This is the report on the large trial that let to the FDA approval of the Novocure device
05/21/12
Study Results of Novocure’s Pivotal Phase 3 Trial Published in European Journal of Cancer Show that NovoTTF™ Therapy was Comparable to Physicians’ First Chemotherapy Choice in Clinical Efficacy with Better Quality of Life Outcomes in Patients with Recurrent Glioblastoma
05/21/12
Further Progress Made For DCVax-L Brain Cancer Clinical Trial
05/21/12
Young At Heart Productions Announces the Making of: Discovering The Beating Path
05/20/12
Revised glioblastoma classification should improve patient care
05/18/12
Olanzapine May Manage Nausea and Vomiting From Chemotherapy When Other Treatments Fail
05/18/12
Northwest Bio Provides Update On DCVax®-L Brain Cancer Trial [Upgraded to phase 3!]
05/16/12
Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton Magnetic Resonance Spectroscopic Imaging Study.
05/16/12
Why dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma.
05/15/12
FAMILY MARATHON The Biers of Milltown run to support brain tumor research
05/14/12
Novocure Announces Launch of Recurrent Glioblastoma Product Website
Displaying Stories 2501 to 2520 of 7673
Previous 20
Next 20
Our privacy / cookie policy has changed.
Click HERE to read it!